Literature DB >> 30688663

Promises, promises, and precision medicine.

Michael J Joyner1, Nigel Paneth2.   

Abstract

Mesh:

Year:  2019        PMID: 30688663      PMCID: PMC6391102          DOI: 10.1172/JCI126119

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

1.  Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric Patients.

Authors:  Jeffrey A SoRelle; Drew M Thodeson; Susan Arnold; Garrett Gotway; Jason Y Park
Journal:  JAMA Pediatr       Date:  2019-01-07       Impact factor: 16.193

Review 2.  Predicting Polygenic Obesity Using Genetic Information.

Authors:  Ruth J F Loos; A Cecile J W Janssens
Journal:  Cell Metab       Date:  2017-03-07       Impact factor: 27.287

3.  Is Precision Medicine an Oxymoron?

Authors:  S Gail Eckhardt; Christopher Lieu
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

4.  Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies.

Authors:  Beate Pesch; Benjamin Kendzia; Per Gustavsson; Karl-Heinz Jöckel; Georg Johnen; Hermann Pohlabeln; Ann Olsson; Wolfgang Ahrens; Isabelle Mercedes Gross; Irene Brüske; Heinz-Erich Wichmann; Franco Merletti; Lorenzo Richiardi; Lorenzo Simonato; Cristina Fortes; Jack Siemiatycki; Marie-Elise Parent; Dario Consonni; Maria Teresa Landi; Neil Caporaso; David Zaridze; Adrian Cassidy; Neonila Szeszenia-Dabrowska; Peter Rudnai; Jolanta Lissowska; Isabelle Stücker; Eleonora Fabianova; Rodica Stanescu Dumitru; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Charles M Rudin; Paul Brennan; Paolo Boffetta; Kurt Straif; Thomas Brüning
Journal:  Int J Cancer       Date:  2011-12-14       Impact factor: 7.396

5.  Epidemiology in wonderland: Big Data and precision medicine.

Authors:  Rodolfo Saracci
Journal:  Eur J Epidemiol       Date:  2018-04-05       Impact factor: 8.082

6.  Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.

Authors:  Christophe Le Tourneau; Jean-Pierre Delord; Anthony Gonçalves; Céline Gavoille; Coraline Dubot; Nicolas Isambert; Mario Campone; Olivier Trédan; Marie-Ange Massiani; Cécile Mauborgne; Sebastien Armanet; Nicolas Servant; Ivan Bièche; Virginie Bernard; David Gentien; Pascal Jezequel; Valéry Attignon; Sandrine Boyault; Anne Vincent-Salomon; Vincent Servois; Marie-Paule Sablin; Maud Kamal; Xavier Paoletti
Journal:  Lancet Oncol       Date:  2015-09-03       Impact factor: 41.316

Review 7.  PCSK9: From discovery to therapeutic applications.

Authors:  Michel Farnier
Journal:  Arch Cardiovasc Dis       Date:  2013-12-27       Impact factor: 2.340

8.  When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis.

Authors:  Jack W Scannell; Jim Bosley
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

9.  Marginal role for 53 common genetic variants in cardiovascular disease prediction.

Authors:  Richard W Morris; Jackie A Cooper; Tina Shah; Andrew Wong; Fotios Drenos; Jorgen Engmann; Stela McLachlan; Barbara Jefferis; Caroline Dale; Rebecca Hardy; Diana Kuh; Yoav Ben-Shlomo; S Goya Wannamethee; Peter H Whincup; Juan-Pablo Casas; Mika Kivimaki; Meena Kumari; Philippa J Talmud; Jacqueline F Price; Frank Dudbridge; Aroon D Hingorani; Steve E Humphries
Journal:  Heart       Date:  2016-06-30       Impact factor: 5.994

Review 10.  The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.

Authors:  Gareth J Hollands; David P French; Simon J Griffin; A Toby Prevost; Stephen Sutton; Sarah King; Theresa M Marteau
Journal:  BMJ       Date:  2016-03-15
View more
  25 in total

1.  How the human genome transformed study of rare diseases.

Authors:  Fowzan S Alkuraya
Journal:  Nature       Date:  2021-02       Impact factor: 49.962

2.  The ownership paradox: nurturing continuity and change for the future ASCI.

Authors:  Kieren A Marr
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

3.  When will individuals meet their personalized probabilities? A philosophical note on risk prediction.

Authors:  Olaf M Dekkers; Jesse M Mulder
Journal:  Eur J Epidemiol       Date:  2020-11-28       Impact factor: 8.082

Review 4.  Mouse Systems Genetics as a Prelude to Precision Medicine.

Authors:  Hao Li; Johan Auwerx
Journal:  Trends Genet       Date:  2020-02-06       Impact factor: 11.639

5.  Polygenic risk scores and the prediction of common diseases.

Authors:  Mika Ala-Korpela; Michael V Holmes
Journal:  Int J Epidemiol       Date:  2020-02-01       Impact factor: 7.196

Review 6.  Complementopathies and precision medicine.

Authors:  Eleni Gavriilaki; Robert A Brodsky
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 7.  The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment.

Authors:  Farhad Islami; Rebecca L Siegel; Ahmedin Jemal
Journal:  Nat Rev Clin Oncol       Date:  2020-05-28       Impact factor: 66.675

Review 8.  Radiomics: from qualitative to quantitative imaging.

Authors:  William Rogers; Sithin Thulasi Seetha; Turkey A G Refaee; Relinde I Y Lieverse; Renée W Y Granzier; Abdalla Ibrahim; Simon A Keek; Sebastian Sanduleanu; Sergey P Primakov; Manon P L Beuque; Damiënne Marcus; Alexander M A van der Wiel; Fadila Zerka; Cary J G Oberije; Janita E van Timmeren; Henry C Woodruff; Philippe Lambin
Journal:  Br J Radiol       Date:  2020-02-26       Impact factor: 3.039

9.  Precision medicine and health disparities: The case of pediatric acute lymphoblastic leukemia.

Authors:  Wylie Burke; Kenneth Thummel
Journal:  Nurs Outlook       Date:  2019-05-14       Impact factor: 3.250

Review 10.  The application of big data to cardiovascular disease: paths to precision medicine.

Authors:  Jane A Leopold; Bradley A Maron; Joseph Loscalzo
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.